Pharmacology members lead team identifying eye-disease drug as a potential response to COVID
![covid](/sites/g/files/oketem666/files/styles/3_2_480x320/public/media/images/Verteporfin%2Band%2BCOVID_0cf44d80-d7c4-46cd-92bd-fdb785e695c8-prv.jpg.webp?itok=vDOu3m-9)
Gustavo Garcia, a former Pharmacology staff researcher, and Dr. Vaithi Arumugaswami are key scientists exploring the Hippo signaling pathway and its response to the drug verteporfin as another avenue to treating COVID-19.